Lower serum zinc in Chronic Fatigue Syndrome (CFS): Relationships to immune dysfunctions and relevance for the oxidative stress status in CFS

Journal of Affective Disorders

Volumn 90, Issue 2-3, 2006, Pages 141-147

  Maes, Michael ^a,b,c   Mihaylova, Ivana ^a,b   De Ruyter, Marcel ^d  

^a MCare4U Outpatient Clinics   (Belgium)

^b Clinical Research Center for Mental Health of Antwerp   (Belgium)

^c VANDERBILT UNIVERSITY   (United States)

^d Salvator Hospital   (Belgium)

Author keywords

Chronic fatigue syndrome; Cytokines; Depression; Immunity; Inflammation; Oxidative stress; Zinc

Indexed keywords

ANTIOXIDANT; CD3 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; ZINC;

ADULT; ARTICLE; ATOMIC ABSORPTION; CD8+ T LYMPHOCYTE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE DYSREGULATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; ZINC BLOOD LEVEL;

ADULT; ALPHA-MACROGLOBULINS; ANTIGENS, CD29; CD8-POSITIVE T-LYMPHOCYTES; DISABILITY EVALUATION; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; OXIDATIVE STRESS; REFERENCE VALUES; T-LYMPHOCYTES, REGULATORY; ZINC;

EID: 31844436261     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2005.11.002     Document Type: Article

References (51)

1. E. Barker, S.F. Fujimura, M.B. Fadem, A.L. Landay, and J.A. Levy Immunologic abnormalities associated with chronic fatigue syndrome Clin. Infect. Disord. 18 supp 1 1994 136 141
2. I. Bremner, and J.H. Beattie Copper and zinc metabolism in health and disease: speciation and interactions Proc. Nutr. Soc. 54 2 1995 489 499
3. M. Cebrian, J. Miguel Redondo, A. Lopez-Rivas, G. Rodriguez-Tarduchy, M.O. De Landazuri, and F. Sanchez-Madrid Expression and function of AIM, an activation inducer molecule of human lymphocytes, is dependent on the activation of protein kinase C Eur. J. Immunol. 19 1989 809 815
4. R.J. Cousins, and A.S. Leinart Tissue-specific regulation of zinc metabolism and metallothionein genes by interleukin-1 FASEB J. 2 1988 2884 2890
5. R. del Rio, M. Rincon, E. Layseca-Espinosa, N.A. Fierro, Y. Rosenstein, and G. Pedraza-Alva PKC theta is required for the activation of human T lymphocytes induced by CD43 engagement Biochem. Biophys. Res. Commun. 325 2004 133 143
6. M.A. Dunn, and R.J. Cousins Kinetics of zinc metabolism in the rat: effect of dibutyryl cAMP Am. J. Physiol. 256 3 Pt 1 1989 E420 E430
7. P.J. Fraker, M.E. Gershwin, and R.A. Good Interrelationships between zinc and immune function Fed. Proc. 45 1986 1476 1479
8. K. Fukuda, S.E. Straus, and I. Hickie The chronic fatigue syndrome: a comprehensive approach to its definition and study Ann. Intern. Med. 121 1994 953 959
9. S.E. Goldblum, D.A. Cohen, M. Jay, and C.J. McClain Interleukin 1-induced depression of iron and zinc: role of granulocytes and lactoferrin Am. J. Physiol. 252 1 Pt 1 1987 E27 E32
10. E. Giroux, P.J. Schechter, and J. Schoun Diminished albumin binding of zinc in serum of pregnant women Clin. Sci. Mol. Med. Suppl. 51 6 1976 545 549
11. R.A. Good, G. Fernandes, and J.A. Garofalo A.S. Prasad Zinc and Immunity: Clinical, Biochemical and Nutritional Aspects of Trace Elements 1982 Liss New York 189
12. G. Kennedy, V.A. Spence, M. McLaren, A. Hill, C. Underwood, and J.J. Belch Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms Free Radic. Biol. Med. 39 5 2005 584 589
13. A.J. Klecha, J. Salgueiro, M. Wald, J. Boccio, M. Zubillaga, N.M. Leonardi, G. Gorelik, and G.A. Cremaschi In vivo iron and zinc deficiency diminished T- and B-selective mitogen stimulation of murine lymphoid cells through protein kinase C-mediated mechanism Biol. Trace Elem. Res. 104 2 2005 173 184
14. N. Klimas, F. Salvato, R. Morgan, and M.A. Fletcher Immunologic abnormalities in chronic fatigue syndrome J. Clin. Microbiol. 28 6 1990 1403 1410
15. A. Linde, B. Anderson, S.B. Svenson, H. Ahrne, M. Carlsson, P. Forsberg, H. Hugo, A. Karlstop, B. Lenkey, and A. Lindwall Serum level of lymphokines and soluble cellular receptors in primary EBV infection and in patients with chronic fatigue syndrome J. Infect. Dis. 165 1992 994 1000
16. A. Lloyd, I. Hickie, C. Hickie, J. Dwyer, and D. Wakefield Cell-mediated immunity in patients with chronic fatigue syndrome, healthy controls and patients with major depression Clin. Exp. Immunol. 87 1 1992 76 79
17. N.M. Lowe, I. Bremner, and M.J. Jackson Plasma 65Zn kinetics in the rat Br. J. Nutr. 65 3 1991 445 455
18. M. Lyall, M. Peakman, and S. Wessely A systematic review and critical evaluation of the immunology of chronic fatigue syndrome J. Psychosom. Res. 55 2 2003 79 90
19. M. Maes Evidence for an immune response in major depression: a review and hypothesis Prog. Neuropsychopharmacol. Biol. Psychiatry 19 1 1995 11 38
20. M. Maes Van Freud tot Omega-3 2005 Standaard Boekhandel Brussels
21. M. Maes, E. Bosmans, E. Suy, C. Vandervorst, C. De Jonckheere, and J. Raus Immune disturbances during major depression: upregulated expression of interleukin-2 receptors Neuropsychobiology 24 3 1990 115 120
22. M. Maes, P. Cosyns, L. Maes, P. D'Hondt, and C. Schotte Clinical subtypes of unipolar depression: Part I. A validation of the vital and nonvital clusters Psychiatry Res. 34 1 1990 29 41
23. M. Maes, P.C. D'Haese, S. Scharpe, P. D'Hondt, P. Cosyns, and M.E. De Broe Hypozincemia in depression J. Affect. Disord. 31 2 1994 135 140
24. M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, H.Y. Meltzer, C. Altamura, and R. Desnyder Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Biol. Psychiatry 42 5 1997 349 358
25. M. Maes, I. Mihaylova, and M. De Ruyter Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in Chronic Fatigue Syndrome (CFS): relevance for the inflammatory response in CFS Neuroendocrinol Lett. 26 5 2005
26. Maes, M., Mihaylova, I., Ategis, J.-C., submitted for publication. Increased serum IgA and IgM against LPS of enterobacteria in Chronic Fatigue Syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of increased gut-intestinal permeability.
27. Mihaylova, I., DeRuyter, M., Rummens, J.-L., Bosmans, E., Maes, M., in press. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
28. A. Morimoto, N. Murakami, T. Nakamori, Y. Sakata, and T. Watanabe Brain regions involved in the development of acute phase responses accompanying fever in rabbits J. Physiol. 416 1989 645 657
29. A. Morimoto, Y. Sakata, T. Watanabe, and N. Murakami Characteristics of fever and acute-phase response induced in rabbits by IL-1 and TNF Am J. Physiol. 256 1 Pt 2 1989 R35 R41
30. H. Mussalo-Rauhamaa, Y.T. Konttinen, J. Lehto, and V. Honkanen Predictive clinical and laboratory parameters for serum zinc and copper in rheumatoid arthritis Ann. Rheum. Dis. 47 1988 816 819
31. National Institute of Allergy and Infectious Diseases, National Institute for Health. Chronic Fatigue Syndrome: Information for physicians. NIH publication September 1996; No 96-484.
32. G. Nowak, M. Kubera, and M. Maes Neuroimmunological aspects of alterations on zinc homeostasis in the pathophysiology and treatment of depression Acta Neuropsychiatr. 12 2000 51 53
33. G. Nowak, M. Siwek, D. Dudek, A. Zieba, and A. Pilc Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study Pol. J. Pharmacol. 55 6 2003 1143 1147
34. G. Nowak, B. Szewczyk, J.M. Wieronska, P. Branski, A. Palucha, A. Pilc, K. Sadlik, and W. Piekoszewski Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats Brain Res. Bull. 61 2 2003 159 164
35. N. Ostrom America's Biggest Cover-Up: 50 More Things Everyone Should Know About The Chronic Fatigue Syndrome Epidemic And Its Link To AIDS http://www.chronicillnet.org/CFS/Ostrom/CFS_book.html 2003
36. R. Patarca, A.M. Lugtendorf, N.G. Klimas, and M.A. Fletcher Dysregulated expression of tumor necrosis factor in the chronic fatigue immune dysfunction syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression Clin. Infect. Dis. 18 1994 147 153
37. A.S. Prasad, J.T. Fitzgerald, J.W. Hess, J. Kaplan, F. Pelen, and M. Dardenne Zinc deficiency in elderly patients Nutrition 9 1993 218 224
38. A.O. Rosa, J. Lin, J.B. Calixto, A.R. Santos, and A.L. Rodrigues Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice Behav. Brain Res. 144 1-2 2003 87 93
39. P. Sarzi-Puttini, F. Atzeni, M. Turiel, R. Furlan, L. Vulpio, M. Carrabba, and F. Pace The Italian version of the Fibrofatigue Scale, a reliable tool for the evaluation of fibromyalgia symptoms J. Psychosom. Res. 56 2 2004 213 216
40. C.M. Shapiro, and H.J. Moller Chronic fatigue: listen and measure J. Psychosom. Res. 52 6 2002 427 436
41. N.W. Solomons Zinc and copper M.E. Shils V.R. Young Modern Nutrition in Health and Disease 1988 Lea & Febiger Philadelphia 238 262
42. U. Srinivas, J.H. Braconier, B. Jeppsson, M. Abdulla, B. Akesson, and P.A. Ockerman Trace element alterations in infectious diseases Scand. J. Clin. Lab. Invest. 48 1988 495 500
43. B. Szewczyk, P. Branski, J.M. Wieronska, A. Palucha, A. Pilc, and G. Nowak Interaction of zinc with antidepressants in the forced swimming test in mice Pol. J. Pharmacol. 54 2002 681 685
44. J.M. Trevillyan, Y.L. Lu, D. Atluru, C.A. Phillips, and J.M. Bjorndahl Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase J. Immunol. 145 1990 3223 3230
45. A.S. Van Miert, C.T. Van Duin, and T. Wensing Fever and changes in plasma zinc and iron concentrations in the goat. The effects of interferon inducers and recombinant IFN-alpha 2a J. Comp. Pathol. 103 1990 289 300
46. S.J. van Rensburg, F.C. Potocnik, T. Kiss, F. Hugo, P. van Zijl, E. Mansvelt, M.E. Carstens, P. Theodorou, P.R. Hurly, R.A. Emsley, and J.J. Taljaard Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities Brain Res. Bull. 55 2 2001 319 325
47. J. Vecchiet, F. Cipollone, K. Falasca, A. Mezzetti, E. Pizzigallo, T. Bucciarelli, S. De Laurentis, G. Affaitati, D. De Cesare, and M.A. Giamberardino Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome Neurosci. Lett. 335 3 2003 151 154
48. J. Visser, B. Blauw, B. Hinloopen, E. Broomer, E.R. de Kloet, C. Kluft, and L. Nagelkerken CD4 lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone J. Infect. Dis. 177 2 1998 451 454
49. M.C. Wichers, G.H. Koek, G. Robaeys, A.J. Praamstra, and M. Maes Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes Psychol. Med. 35 3 2005 433 441
50. O. Zachrisson, B. Regland, M. Jahreskog, M. Kron, and C.G. Gottfries A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale) J. Psychosom. Res. 52 6 2002 501 509
51. M.H. Zweig, and G. Campbell Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine Clin. Chem. 39 1993 561 577